bell
The current prices are delayed by 15 mins, login to check live prices.
Lyka Labs Ltd share price logo

Lyka Labs Share Price

(LYKALABS)

₹151.83.56%

as on 12:09PM, 22 Jan 2025

Overview
News
Financials
Q3 2024 Results
Technicals

Lyka Labs Performance

  • Day's Low

    Day's High

    ₹151.65
    Day's Price Range
    ₹158.93
  • 52 Week's Low

    52 Week's High

    ₹97.9
    52-Week Price Range
    ₹176.59
1 Month Return+ 5.05 %
3 Month Return+ 13.82 %
1 Year Return+ 33.96 %
Previous Close₹157.40
Open₹151.80
Volume1.20L
Upper Circuit-
Lower Circuit-
Market Cap₹561.76Cr

Lyka Labs Key Statistics

P/E Ratio-67.84
PEG Ratio-21.96
Market Cap₹561.76 Cr
P/B Ratio3.88
EPS-0.79
Dividend Yield0
SectorPharmaceuticals
ROE0

Lyka Labs Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹561.76 Cr128.49%0.69-₹3 Cr₹111 Cr
BUY₹12,423.88 Cr-3.8%0.52₹602 Cr₹2,851 Cr
NA₹1,067.07 Cr-1.52%0.56₹41 Cr₹338 Cr
NA₹3,528.84 Cr766.04%0.51NANA
NA₹21,764.79 Cr84.32%0.77-₹472 Cr₹2,798 Cr

About Lyka Labs

Lyka Labs, a bulk drug company, has been in the business of offering lifesaving antibiotics and treating minor infections for over three decades. Over the years, the company has also diversified into marketing medical and diagnostic machinery and equipment, ayurvedic and animal health care products, tropical steroids, anticancer products, cardiovascular drugs, and anti-inflammatory products. In the year 1991 they received a Certificate of Merit for their impressive export performance and an award from CHEMEXCIL. Two years later, their Administrative Office and Plant at Tarapur was awarded the ISO 9002 certification for its quality management system. As part of its diversification, the company had also invested in Relic Finance and acquired 26.70% of the company's paid-up equity capital through a public offer. They also launched India's first Glutathione Injection formulation during 2012-13 to become one of India's leading healthcare and pharmaceutical companies.

Share Price: ₹151.80 per share as on 22 Jan, 2025 12:09 PM
Market Capitalisation: ₹561.76Cr as of today
Revenue: ₹41.16Cr as on September 2024 (Q3 24)
Net Profit: ₹2.10Cr as on September 2024 (Q3 24)
Listing date: 08 Feb, 1995
Chairperson Name: KUNAL NARENDRA GANDHI
OrganisationLyka Labs
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Lyka Labs Ltd

  • Lyka Labs Reports Strong Q3 Growth in Sales and Profit - 25 Nov, 2024

    Lyka Labs reported a 47.05% increase in net sales to Rs 41.16 crore for September 2024, with net profit soaring 530.91% to Rs 2.10 crore. EBITDA rose 12.67%, and EPS increased to Rs 0.58. The stock has delivered 27.18% returns over the past six months.
  • Lyka Labs Reports Strong Q3 Growth in Sales and Profit - 13 Nov, 2024

    Lyka Labs reported a 53.79% increase in standalone net sales to Rs 41.16 crore for September 2024, with net profit soaring 946.01% to Rs 2.47 crore. EBITDA rose 29.01%, and EPS increased to Rs 0.69. The stock has delivered 28.05% returns over the last six months.

Insights on Lyka Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -2.13 Cr → 2.1 Cr (in ₹), with an average increase of 139.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, LYKALABS stock has moved up by 35.3%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 28.08 Cr → 41.18 Cr (in ₹), with an average increase of 17.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 103.2% return, outperforming this stock by 139.0%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 41.08% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 46.6% return, outperforming this stock by 24.1%

  • imgNO EFFECT

    FII Holding Unchanged

    img

    Foreign Institutions holdings remained unchanged at 0.15% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 58.10% of holdings in Dec 2024 quarter

Lyka Labs Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹27.99Cr (-)₹32.56Cr (↑16.33%)₹27.77Cr (↓14.71%)₹30.11Cr (↑8.43%)₹41.16Cr (↑36.70%)
Net Income-₹0.49Cr (-)₹1.78Cr (↓463.27%)-₹2.13Cr (↓219.66%)₹1.44Cr (↓167.61%)₹2.10Cr (↑45.83%)
Net Profit Margin-1.75% (-)5.47% (↓412.57%)-7.67% (↓240.22%)4.78% (↓162.32%)5.10% (↑6.69%)
Value in ₹ crore
Details2021202220232024
Total Assets₹213.37Cr (-)₹208.51Cr (↓2.28%)₹178.86Cr (↓14.22%)₹185.89Cr (↑3.93%)
Total Liabilities₹208.25Cr (-)₹163.29Cr (↓21.59%)₹101.35Cr (↓37.93%)₹85.48Cr (↓15.66%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹11.45Cr (-)₹5.75Cr (↓150.22%)₹76.53Cr (↑1,230.96%)₹6.87Cr (↓91.02%)₹3.09Cr (↓55.02%)

Lyka Labs Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
58.1%
0.00
Foreign Institutions
0.15%
0.13
Mutual Funds
0.01%
0.00
Retail Investors
41.08%
0.00
Others
0.66%
0.00

Lyka Labs Key Indicators

Details20202021202220232024
Earning Per Share (₹)-21.83-3.5213.4-4.29-0.79
Details2022
Return On Equity %58.27
Details20202021202220232024
Return On Assets %-27.36-5.4118.7-7.39-1.34
Details20202021202220232024
Book Value Per Share (₹)-5-8.994.659.1217.86

Lyka Labs Valuation

Lyka Labs in the last 5 years

  • Overview

  • Trends

Lowest (-164.66x)

September 10, 2018

Today (-67.84x)

January 21, 2025

Industry (55.69x)

January 21, 2025

Highest (23.04x)

September 5, 2022

LowHigh

Lyka Labs Earnings and Dividends

  • Lyka Labs Ltd Earnings Results

    Lyka Labs Ltd’s net profit jumped 528.57% since last year same period to ₹2.10Cr in the Q2 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 45.83% jump in its net profits since last 3-months.

    Read More about Earnings Results

Lyka Labs Technicals Summary

Bearish

Neutral

Bullish

Bearish

Lyka Labs Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Lyka Labs Ltd

Lyka Labs Ltd share price today stands at ₹151.8, Open. ₹151.8 ; Previous Close. ₹157.4 ; High. ₹158.93 ; Low. ₹151.65 ; 52 Week High. ₹176.59 ; 52 Week Low: ₹97.9.

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Lyka Labs Ltd shares.

Lyka Labs Ltd is listed on NSE

Lyka Labs Ltd is listed on BSE

  • Today’s highest price of Lyka Labs Ltd is ₹158.93.
  • Today’s lowest price of Lyka Labs Ltd is ₹151.65.

PE Ratio of Lyka Labs Ltd is -67.84

PE ratio = Lyka Labs Ltd Market price per share / Lyka Labs Ltd Earnings per share

Today’s traded volume of Lyka Labs Ltd(LYKALABS) is 1.20L.

Today’s market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹561.76Cr.

Lyka Labs Ltd(LYKALABSPrice
52 Week High
₹176.59
52 Week Low
₹97.9

Lyka Labs Ltd(LYKALABS) share price is ₹151.8. It is down -14.04% from its 52 Week High price of ₹176.59

Lyka Labs Ltd(LYKALABS) share price is ₹151.8. It is up 55.06% from its 52 Week Low price of ₹97.9

Lyka Labs Ltd(LYKALABSReturns
1 Day Returns
-5.6%
1 Month Returns
5.05%
3 Month Returns
13.82%
1 Year Returns
33.96%